|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.87 USD | -1.46% |
|
+0.83% | +6.72% |
| Capitalization | 161.61Cr 138.68Cr 129.12Cr 120.16Cr 224.22Cr 15TCr 241.72Cr 1.48TCr 584Cr 6.98TCr 606.09Cr 593.6Cr 26TCr | P/E ratio 2026 * |
20x | P/E ratio 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise value | 216.25Cr 185.56Cr 172.77Cr 160.78Cr 300.03Cr 20TCr 323.44Cr 1.99TCr 781.45Cr 9.34TCr 811.01Cr 794.29Cr 34TCr | EV / Sales 2026 * |
1.48x | EV / Sales 2027 * | 1.36x |
| Free-Float |
49.93% | Yield 2026 * |
1.2% | Yield 2027 * | 1.2% |
Last Transcript: Phibro Animal Health Corporation
| 1 day | -1.46% | ||
| 1 week | +0.83% | ||
| Current month | +6.72% | ||
| 1 month | -0.70% | ||
| 3 months | +8.99% | ||
| 6 months | +29.45% | ||
| Current year | +6.72% |
| 1 week | 38 |  | 41.27 |
| 1 month | 36.14 | | 41.59 |
| Current year | 36.47 | | 41.27 |
| 1 year | 16.16 | | 46.42 |
| 3 years | 9.4 | | 46.42 |
| 5 years | 9.4 | | 46.42 |
| 10 years | 9.4 | | 54.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 79 | 01/03/2014 |
Glenn David
DFI | Director of Finance/CFO | 55 | 09/02/2024 |
| Chief Tech/Sci/R&D Officer | 50 | 01/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Bendheim
CHM | Chairman | 79 | 01/05/2002 |
Daniel Bendheim
BRD | Director/Board Member | 54 | 01/11/2013 |
E. Corcoran
BRD | Director/Board Member | 79 | 01/05/2008 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.12% | 0.33% | 22 M€ | |
| +4.33% | 0.32% | 29 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.46% | +0.83% | +96.69% | +171.41% | 164Cr | |
| +0.98% | -2.71% | -24.34% | -21.80% | 5.49TCr | |
| -0.04% | +2.69% | +108.89% | +86.85% | 1.21TCr | |
| -1.10% | -1.53% | -22.53% | +4.89% | 402.18Cr | |
| -0.28% | +1.41% | +14.81% | +42.49% | 352.45Cr | |
| -0.29% | +7.45% | +172.01% | +67.64% | 271.77Cr | |
| -2.07% | +4.33% | -16.20% | +3.71% | 183.62Cr | |
| -0.55% | +1.27% | +15.29% | +4.79% | 130.31Cr | |
| -1.61% | +0.13% | +28.16% | -37.69% | 117.83Cr | |
| +0.12% | +0.82% | +20.82% | -12.08% | 117.78Cr | |
| Average | -0.63% | +1.82% | +39.36% | +31.02% | 844.67Cr | |
| Weighted average by Cap. | +0.46% | +1.37% | +7.36% | +5.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 146.57Cr 125.77Cr 117.1Cr 108.97Cr 203.35Cr 13TCr 219.22Cr 1.35TCr 529.65Cr 6.33TCr 549.68Cr 538.35Cr 23TCr | 151.38Cr 129.9Cr 120.95Cr 112.55Cr 210.03Cr 14TCr 226.42Cr 1.39TCr 547.04Cr 6.54TCr 567.73Cr 556.03Cr 24TCr |
| Net income | 8.16Cr 7Cr 6.52Cr 6.06Cr 11Cr 736.33Cr 12Cr 75Cr 29Cr 352.23Cr 31Cr 30Cr 1.29TCr | 9.92Cr 8.51Cr 7.92Cr 7.37Cr 14Cr 895.21Cr 15Cr 91Cr 36Cr 428.24Cr 37Cr 36Cr 1.57TCr |
| Net Debt | 55Cr 47Cr 44Cr 41Cr 76Cr 4.93TCr 82Cr 501.9Cr 197.45Cr 2.36TCr 204.92Cr 200.69Cr 8.65TCr | 45Cr 38Cr 36Cr 33Cr 62Cr 4.04TCr 67Cr 411.1Cr 161.73Cr 1.93TCr 167.85Cr 164.39Cr 7.08TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 39.87 $ | -1.46% | 1,94,182 |
| 13/26/13 | 40.46 $ | +1.58% | 1,59,243 |
| 12/26/12 | 39.83 $ | +0.99% | 2,70,553 |
| 09/26/09 | 39.44 $ | -0.70% | 1,63,725 |
| 08/26/08 | 39.72 $ | +0.74% | 1,53,681 |
Delayed Quote Nasdaq, January 15, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PAHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition